A rare case of an oligodendroglioma of the cerebellum in an 18-year-old male is presented. Radical surgical excision and craniospinal radiotherapy appear to be the treatment options for these potentially malignant lesions.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jocn.2004.10.007 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Non-hemorrhagic cerebellar contrast enhancement on intraoperative MRI during a supratentorial glioma resection: Concerning finding of no significance.
Radiol Case Rep
August 2024
Department of Neurosurgery, Medical College of Wisconsin, Wauwatosa, WI, USA.
Intraoperative magnetic resonance imaging (iMRI) is a powerful tool used to verify maximal safe resection of gliomas. However, unsuspected new or incidental findings can present difficult clinical scenarios. Here we present a case of a large supratentorial glioma resection where new, incidental bilateral cerebellar hemispheric enhancement was noted on iMRI.
View Article and Find Full Text PDFCerebellar mass in a 31-year-old woman.
Brain Pathol
July 2024
Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Diffuse Leptomeningeal Glioneuronal Tumor in Adults: Case Report and Literature Review.
Case Rep Oncol
February 2024
Department of Neurosurgery, Klinikum der Goethe Universität Frankfurt, Frankfurt, Germany.
Introduction: Diffuse leptomeningeal glioneuronal tumor (DLGNT), a new addition to the 2016 World Health Organization (WHO) classification, is a rare childhood neoplasm presenting with disseminated leptomeningeal enhancement and an occasional intraparenchymal mass. Diagnosis is often impeded by infectious/immunological differentials, necessitating a biopsy to confirm the diagnosis. We report an adult male with DLGNT without hydrocephalus, which is rare in patients with cerebellar masses.
View Article and Find Full Text PDFDistant recurrence in the cerebellar dentate nucleus through the dentato-rubro-thalamo-cortical pathway in supratentorial glioma cases.
Acta Neurochir (Wien)
February 2024
Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
Background: Distant recurrence can occur by infiltration along white matter tracts or dissemination through the cerebrospinal fluid (CSF). This study aimed to clarify the clinical features and mechanisms of recurrence in the dentate nucleus (DN) in patients with supratentorial gliomas. Based on the review of our patients, we verified the hypothesis that distant DN recurrence from a supratentorial lesion occurs through the dentato-rubro-thalamo-cortical (DRTC) pathway.
View Article and Find Full Text PDFSystematic characterization of antibody-drug conjugate targets in central nervous system tumors.
Neuro Oncol
March 2024
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Article Synopsis
- Antibody-drug conjugates (ADCs) are designed to deliver chemotherapeutic agents to specific cancer cells, and recent research shows that even low levels of target proteins like HER2 can lead to effective treatment in certain brain tumors.
- A study analyzing gene expression data from over 500 CNS tumors revealed that various tumor types express different ADC targets, with ependymomas having high HER2 levels, while meningiomas and other tumors exhibited specific patterns of target protein expression.
- The findings suggest that understanding the unique expression profiles of ADC targets in CNS tumors can guide future treatment strategies and help develop new therapies tailored for specific cancer types.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!